High-Speed Imaging for Cardiovascular Disease Diagnosis
The new imaging technique reveals the presence of carbon-hydrogen bonds making up lipid molecules in arterial plaques that cause heart disease. "This allows us to see the exact nature of plaque formation in the walls of arteries so we can define whether plaque is going to rupture," said Michael Sturek, co-author of the study and a professor and chair of the Department of Cellular & Integrative Physiology at Indiana University School of Medicine.
Laser-Based Intravascular Photoacoustic Imaging
Some plaques are more dangerous than others, and it is important to know the chemical makeup of the blood vessel wall "to determine which ones are at risk of rupturing," Sturek noted. However, research in the area has been hampered by the inability to perform high-speed imaging in tissue. To overcome the problem, the researchers developed a Raman laser using a laser that produces 2,000 pulses per second. Each pulse is able to generate an image, representing a 100-fold increase in the imaging speed of the new technology, called intravascular photoacoustic imaging.
"This innovation represents a big step toward advancing this technology to the clinical setting," said Ji-Xin Cheng, a professor in Purdue University's Weldon School of Biomedical Engineering and Department of Chemistry. The collaborative work included researchers from Purdue, Indiana University School of Medicine, the University of Southern California, the University of California at Irvine, and startup company Spectral Energy.
The laser, which pulses in the near-infrared range of the spectrum, causes tissue to heat and expand locally, generating pressure waves at the ultrasound frequency that can be picked up with a device called a transducer, the research team explained. The near-infrared laser causes enough heating to generate ultrasound but not enough to damage the tissues. The research was conducted with intact pig tissue and will expand to research with live animals and then clinical studies with humans.
‘Label Free’ Imaging Technique is Ideal for Diagnostic Uses
The "label free" imaging technique does not require samples to be marked with dyes, making it ideal for diagnostic applications. Also, the system is small enough to be incorporated into an endoscope to put into blood vessels using a catheter, Cheng said.
The new imaging technology is being commercialised by the company Vibronix Inc., co-founded by Cheng and Purdue postdoctoral research associate Pu Wang. The Purdue Office of Technology Commercialization has filed a US patent application.
The study was authored by Wang; Purdue research scientist Mikhail N. Slipchenko; Purdue graduate student Jie Hui; USC graduate students Teng Ma and Shanshan Liang; USC researcher Qifa Zhou; K. Kirk Shung, director of the Ultrasonic Transducer Resource Center at USC; Sukesh Roy, CEO of Spectral Energy LLC in Dayton, Ohio; Sturek; Zhongping Chen, a researcher at UC Irvine; and Cheng.
Funding sources for the research included the National Institutes of Health and the American Heart Association.
Image Credit: Purdue University Weldon School of Biomedical Engineering/Ji-Xin Cheng
Published on : Wed, 5 Nov 2014
The Task Force® Monitor is the all‐in‐one workstation for continuous noninvasive hemodynamic and autonomic assessment. It is the state‐of‐the‐art diagnostic tool to study syncope and autoregulation of blood pressure and has further established as an...
The CNAP® Monitor represents the next generation of noninvasive patient monitoring by merging the advantages of noninvasive, risk‐free methods with the benefits of continuity in the same accuracy as invasive standards. The advanced parameter set enables...